Evidence map›Paper›PMID 32064766›Full record

ArticleJournal of the International AIDS Society2020

Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics.

Austin Tucker, Tannia Tembo, Radhika P Tampi, Jacob Mutale, Mpande Mukumba-Mwenechanya, Anjali Sharma, David W Dowdy, Carolyn B Moore, Elvin Geng, Charles B Holmes and 2 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Efficiency of TB service provision in the public and private health sectors in Ethiopia.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
  4. Article
  5. Determining the value of TB active case-finding: current evidence and methodological considerations.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Austin TuckerDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-3397-2565
Tannia TemboCenter for Infectious Disease Research (CIDRZ), Lusaka, Zambia.ORCID 0000-0003-3800-371X
Radhika P TampiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-6953-7768
Jacob MutaleCenter for Infectious Disease Research (CIDRZ), Lusaka, Zambia.ORCID 0000-0002-8914-0645
Mpande Mukumba-MwenechanyaCenter for Infectious Disease Research (CIDRZ), Lusaka, Zambia.ORCID 0000-0002-4753-5075
Anjali SharmaCenter for Infectious Disease Research (CIDRZ), Lusaka, Zambia.ORCID 0000-0002-8189-0732
David W DowdyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0003-0481-7475
Carolyn B MooreCenter for Infectious Disease Research (CIDRZ), Lusaka, Zambia.ORCID 0000-0001-9103-7746
Elvin GengDepartment of Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.ORCID 0000-0002-0825-1424
Charles B HolmesCenter for Infectious Disease Research (CIDRZ), Lusaka, Zambia.ORCID 0000-0002-7924-6761
Izukanji SikazweCenter for Infectious Disease Research (CIDRZ), Lusaka, Zambia.ORCID 0000-0002-3898-2607
Hojoon SohnDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0001-5837-3844

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAccurate costing is key for programme planning and policy implementation. Since 2011, there have been major changes in eligibility criteria and treatment regimens with price reductions in ART drugs, programmatic changes resulting in clinical task-shifting and decentralization of ART delivery to peripheral health centres making existing evidence on ART care costs in Zambia out-of-date. As decision makers consider further changes in ART service delivery, it is important to understand the current drivers of costs for ART care. This study provides updates on costs of ART services for HIV-positive patients in Zambia.

methodsWe evaluated costs, assessed from the health systems perspective and expressed in 2016 USD, based on an activity-based costing framework using both top-down and bottom-up methods with an assessment of process and capacity. We collected primary site-level costs and resource utilization data from government documents, patient chart reviews and time-and-motion studies conducted in 10 purposively selected ART clinics.

resultsThe cost of providing ART varied considerably among the ten clinics. The average per-patient annual cost of ART service was $116.69 (range: $59.38 to $145.62) using a bottom-up method and $130.32 (range: $94.02 to $162.64) using a top-down method. ART drug costs were the main cost driver (67% to 7% of all costs) and are highly sensitive to the types of patient included in the analysis (long-term vs. all ART patients, including those recently initiated) and the data sources used (facility vs. patient level). Missing capacity costs made up 57% of the total difference between the top-down and bottom-up estimates. Variability in cost across the ten clinics was associated with operational characteristics.

conclusionsReal-world costs of current routine ART services in Zambia are considerably lower than previously reported estimates and sensitive to operational factors and methods used. We recommend collection and monitoring of resource use and capacity data to periodically update cost estimates.

Indexed as

Anti-HIV AgentsHealth Care CostsHIV InfectionsHumansZambiaAnti-HIV AgentsAIDSantiretroviral therapycosts and cost analysisHIVlow-resource settingZambia

Identifiers

PMID32064766
PMCPMC7025092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.